Another study suggested that although tumor-infiltrating CD8+ lymphocytes (TILs) have a predictive value that varies by tumor and nodal stage, they are linked to a decreased recurrence of CRC [98]. The gene discussed is CD8A; the disease is colorectal carcinoma.